Browsing: Investors

Amgen Inc. (ISIN US0311621009) stock sits in the large-cap pharma bracket with investors closely watching how recent double-digit revenue growth and the integration of Horizon Therapeutics translate into future earnings power. In 2023 Amgen reported revenue of roughly $28.2 billion, up around 7% from about $26.3 billion in 2022, while the company continued to return…

Medifast Inc (ISIN US58470S1024) is a US-based nutrition and weight-loss company whose shares trade in the United States, giving retail investors direct exposure to the evolving weight-management and wellness market. The company has been adjusting its strategy as demand patterns shift across the industry and as consumers increasingly look for structured programs that combine nutrition,…